HealthTell Develops Innovative New Way to Monitor Patient Health Status

HealthTell, winner of the 2012 “Innovator of the Year, Start-Up Company,” was praised by the Arizona Technology Council for its development of a new method of monitoring patients’ health statuses. HealthTell’s technology takes a novel approach to the problem of detecting cancer and infectious diseases before they spread or become harder to treat. Unlike other methods which focus on measuring the pathogen and require complicated and expensive monitoring devices, HealthTell’s Click here to read more…

Full Story

First Prevention Trial for Alzheimer’s Disease: Crenezumab Tests Begin in Early 2013

Crenezumab, an experimental Alzheimer’s drug manufactured by Genentech, will be the first drug to be tested for efficacy in Alzheimer’s prevention. The drug was chosen from a pool of 25 competitors, primarily because Crenezumab–unlike many similar drugs–does not cause vasogenic edema (brain swelling). The landmark trials are slated to begin in early 2013 and will be important in determining whether early intervention can prevent or slow the onset of Alzheimer’s Click here to read more…

Full Story

Sanofi Cuts Price of Cancer Drug Zaltrap in Half

After Memorial Sloan-Kettering Cancer Center in New York (one of the leading cancer care institutions in the country) decided not to use the colon cancer drug Zaltrap due to the drug’s price, manufacturer Sanofi announced that it would reduce the price of Zaltrap by about half. (The official price for Zaltrap has not been changed, but Sanofi will offer discounts of about 50%.)   Doctors from Sloan-Kettering claimed that the Zaltrap, Click here to read more…

Full Story

Mandatory Labeling for Genetically Modified Food: Proposition 37 in California Defeated

Proposition 37 in California, a ballot measure that would require labeling of genetically modified food, was defeated 53.1% to 46.9%. Advocates of the ballot claim that people have a right to know what is in their food, also noting that other countries require such labeling and that genetically engineered food has not been subject to sufficient testing. Despite having initial support for Proposition 37 (at one point over 60%), the Click here to read more…

Full Story